• 2012
    • Daniels, A., Linz, D., van Bilsen, M., Ruetten, H., Sadowski, T., Ruf, S., Juretschke, H.-P., Neumann-Haefelin, C., Munts, C., van der Vusse, G. J., & van Nieuwenhoven, F. A. (2012). Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats. European journal of heart failure, 14(2), 193-201. https://doi.org/10.1093/eurjhf/hfr166
    • Maesen, B., Nijs, J., Maessen, J., Allessie, M., & Schotten, U. (2012). Post-operative atrial fibrillation: a maze of mechanisms. EP Europace, 14(2), 159-174. https://doi.org/10.1093/europace/eur208
    • Johnson, D. M., de Jong, M. M. J., Crijns, H. J. G. M., Carlsson, L. G., & Volders, P. G. A. (2012). Reduced Ventricular Proarrhythmic Potential of the Novel Combined Ion-Channel Blocker AZD1305 Versus Dofetilide in Dogs With Remodeled Hearts. Circulation-Arrhythmia and Electrophysiology, 5(1), 201-U328. https://doi.org/10.1161/CIRCEP.111.963025
    • Hermeling, E., Vermeersch, S. J., Rietzschel, E. R., de Buyzere, M. L., Gillebert, T. C., van de Laar, R. J., Ferreira, I., Hoeks, A. P., van Bortel, L. M., Reneman, R. S., Segers, P., & Reesink, K. D. (2012). The change in arterial stiffness over the cardiac cycle rather than diastolic stiffness is independently associated with left ventricular mass index in healthy middle-aged individuals. Journal of Hypertension, 30(2), 396-402. https://doi.org/10.1097/HJH.0b013e32834e4b75
    • Bieghs, V., van Gorp, P. J., Wouters, K., Hendrikx, T., Gijbels, M. J., van Bilsen, M., de Bakker, J., Binder, C. J., Lutjohann, D., Staels, B., Hofker, M. H., & Sverdlov, R. (2012). LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease. PLOS ONE, 7(1), Article e30668. https://doi.org/10.1371/journal.pone.0030668
    • Heijman, J., Spätjens, R. L. H., Seyen, S. R. M., Lentink, V., Kuijpers, H. J. H., Boulet, I. R., de Windt, L. J., David, M., & Volders, P. G. A. (2012). Dominant-Negative Control of cAMP-Dependent I-Ks Upregulation in Human Long-QT Syndrome Type 1. Circulation Research, 110(2), 211–219. https://doi.org/10.1161/CIRCRESAHA.111.249482
    • Bons, J. A., Havekes, B., Volders, P. G., de Zwaan, C., Kema, I. P., Wodzig, W. K., & Menheere, P. P. (2012). Assay-specific pitfalls of catecholamine hplc assays. Clinical Chemistry and Laboratory Medicine, 50(10), 1853-6. https://doi.org/10.1515/cclm-2012-0024
    • Kalder, J., Keschenau, P., Hanssen, S. J. P., Greiner, A., Vermeulen Windsant, I. C., Kennes, L. N., Tolba, R., Prinzen, F. W., Buurman, W. A., Jacobs, M. J. H. M., & Koeppel, T. A. (2012). The impact of selective visceral perfusion on intestinal macrohemodynamics and microhemodynamics in a porcine model of thoracic aortic cross-clamping.Journal of Vascular Surgery, 56(1), 149-158. https://doi.org/10.1016/j.jvs.2011.11.126
    • van Wijk, S., Jacobs, L., Eurlings, L. W., van Kimmenade, R., Lemmers, R., Broos, P., Bekers, O., Prins, M. H., Crijns, H. J., Pinto, Y. M., van Dieijen-Visser, M. P., & Brunner-La Rocca, H. P. (2012). Troponin T Measurements by High-Sensitivity vs Conventional Assays for Risk Stratification in Acute Dyspnea. Clinical Chemistry, 58(1), 284-292. https://doi.org/10.1373/clinchem.2011.175976
    • Kirchhof, P., Lip, G. Y. H., Van Gelder, I. C., Bax, J., Hylek, E., Kaab, S., Schotten, U., Wegscheider, K., Boriani, G., Brandes, A., Ezekowitz, M. D., Diener, H.-C., Haegeli, L., Heidbuchel, H., Lane, D. A., Mont, L., Willems, S., Dorian, P., Aunes-Jansson, M., ... Camm, A. J. (2012). Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. EP Europace, 14(1), 8-27. https://doi.org/10.1093/europace/eur241
    • Versteylen, M. O., Bekkers, S. C. A. M., Smulders, M. W., Winkens, B., Mihl, C., Winkens, M. H. M., Leiner, T., Waltenberger, J. L., Kim, R. J., & Gorgels, A. P. M. (2012). Performance of angiographic, electrocardiographic and MRI methods to assess the area at risk in acute myocardial infarction. Heart, 98(2), 109-115. https://doi.org/10.1136/heartjnl-2011-300185
    • Leenders, G. E., Lumens, J., Cramer, M. J., De Boeck, B. W. L., Doevendans, P. A., Delhaas, T., & Prinzen, F. W. (2012). Septal Deformation Patterns Delineate Mechanical Dyssynchrony and Regional Differences in Contractility Analysis of Patient Data Using a Computer Model. Circulation-Heart Failure, 5(1), 87-96. https://doi.org/10.1161/CIRCHEARTFAILURE.111.962704
    • Kornet, L., van Hunnik, A., Michels, K., Verheule, S., Della Scala, A., West, T., Kessels, R., & Cornelussen, R. (2012). Stimulation of the intra-cardiac vagal nerves innervating the AV-node to control ventricular rate during AF: specificity, parameter optimization and chronic use up to 3 months. Journal of Interventional Cardiac Electrophysiology, 33(1), 7-18. https://doi.org/10.1007/s10840-011-9619-4
    • Kroon, W., Huberts, W., Bosboom, M., & van de Vosse, F. (2012). A Numerical Method of Reduced Complexity for Simulating Vascular Hemodynamics Using Coupled 0D Lumped and 1D Wave Propagation Models. Computational and Mathematical Methods in Medicine, 2012, Article 156094. https://doi.org/10.1155/2012/156094
    • ter Bekke, R. M. A., & Volders, P. G. A. (2012). Arrhythmogenic mechano-electric heterogeneity in the long-QT syndrome. Progress in Biophysics & Molecular Biology, 110(2-3), 347-358. https://doi.org/10.1016/j.pbiomolbio.2012.07.007
    • van der Weg, K., Bekkers, S. C. A. M., Winkens, B., Lemmert, M. E., Schalla, S., Crijns, H. J. G. M., Waltenberger, J., & Gorgels, A. P. M. (2012). Evaluation of the electrocardiogram in identifying and quantifying lateral involvement in nonanterior wall infarction using cardiovascular magnetic resonance imaging. Journal of Electrocardiology, 45(5), 478-484. https://doi.org/10.1016/j.jelectrocard.2012.04.008
    • Hermeling, E., Delhaas, T., Prinzen, F. W., & Kuijpers, N. H. L. (2012). Mechano-electrical feedback explains T-wave morphology and optimizes cardiac pump function: Insight from a multi-scale model. Progress in Biophysics & Molecular Biology, 110(2-3), 359-371. https://doi.org/10.1016/j.pbiomolbio.2012.07.008
    • Cluitmans, M. J. M., Peeters, R. L. M., Volders, P. G. A., & Westra, R. L. (2012). Realistic training data improve noninvasive reconstruction of heart-surface potentials. IEEE Engineering in Medicine and Biology Society, 2012, 6373-6. https://doi.org/10.1109/EMBC.2012.6347452
  • 2011
    • Kowey, P. R., Crijns, H. J. G. M., Aliot, E. M., Capucci, A., Kulakowski, P., Radzik, D., Roy, D., Connolly, S. J., & Hohnloser, S. H. (2011). Efficacy and Safety of Celivarone, With Amiodarone as Calibrator, in Patients With an Implantable Cardioverter-Defibrillator for Prevention of Implantable Cardioverter-Defibrillator Interventions or Death The ALPHEE Study. Circulation, 124(24), 2649-U204. https://doi.org/10.1161/CIRCULATIONAHA.111.072561
    • Weseler, A. R., Ruijters, E. J. B., Reesink, K. D., Haenen, G. R. M. M., & Bast, A. (2011). Pleiotropic benefit of monomeric and oligomeric flavanols on vascular health - a randomized controlled clinical pilot study. PLOS ONE, 6(12), Article 28460. https://doi.org/10.1371/journal.pone.0028460
    • Weijs, B., De Vos, C. B., Tieleman, R. G., Pisters, R., Cheriex, E. C., Prins, M. H., & Crijns, H. J. G. M. (2011). Clinical and echocardiographic correlates of intra-atrial conduction delay. EP Europace, 13(12), 1681-1687. https://doi.org/10.1093/europace/eur261
    • Linz, D., Schotten, U., Neuberger, H.-R., Boehm, M., & Wirth, K. (2011). Combined blockade of early and late activated atrial potassium currents suppresses atrial fibrillation in a pig model of obstructive apnea. Heart Rhythm, 8(12), 1933-1939. https://doi.org/10.1016/j.hrthm.2011.07.018
    • Kirchhof, P., Lip, G. Y. H., Van Gelder, I. C., Bax, J., Hylek, E., Kaeaeb, S., Schotten, U., Wegscheider, K., Boriani, G., Ezekowitz, M. D., Diener, H.-C., Heidbuchel, H., Lane, D. A., Mont, L., Willems, S., Dorian, P., Vardas, P., Breithardt, G., & Camm, A. J. (2011). Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference. Thrombosis and Haemostasis, 106(6), 1012-1019. https://doi.org/10.1160/TH11-07-0517
    • van Geldorp, I. E., Delhaas, T., Gebauer, R. A., Frias, P., Tomaske, M., Friedberg, M. K., Tisma-Dupanovic, S., Elders, J., Fruh, A., Gabbarini, F., Kubus, P., Illikova, V., Tsao, S., Blank, A. C., Hiippala, A., Sluysmans, T., Karpawich, P., Clur, S.-A., Ganame, X., ... Janousek, J. (2011). Impact of the permanent ventricular pacing site on left ventricular function in children: a retrospective multicentre survey. Heart, 97(24), 2051-2055. https://doi.org/10.1136/heartjnl-2011-300197
    • van Loon, R. L. E., Roofthooft, M. T. R., Hillege, H. L., ten Harkel, A. D. J., van Osch-Gevers, M., Delhaas, T., Kapusta, L., Strengers, J. L. M., Rammeloo, L. A. J., Clur, S.-A. B., Mulder, B. J. M., & Berger, R. M. F. (2011). Pediatric Pulmonary Hypertension in the Netherlands Epidemiology and Characterization During the Period 1991 to 2005. Circulation, 124(16), 1755-U136. https://doi.org/10.1161/CIRCULATIONAHA.110.969584
    • Groenveld, H. F., Crijns, H. J. G. M., Van den Berg, M. P., Van Sonderen, E., Alings, A. M., Tijssen, J. G. P., Hillege, H. L., Tuininga, Y. S., van Veldhuisen, D. J., Ranchor, A. V., & Van Gelder, I. C. (2011). The Effect of Rate Control on Quality of Life in Patients With Permanent Atrial Fibrillation Data From the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) Study. Journal of the American College of Cardiology, 58(17), 1795-1803. https://doi.org/10.1016/j.jacc.2011.06.055
    • Bogaard, M. D., Houthuizen, P., Bracke, F. A., Doevendans, P. A., Prinzen, F. W., Meine, M., & van Gelder, B. M. (2011). Baseline left ventricular dP/dt(max) rather than the acute improvement in dP/dt(max) predicts clinical outcome in patients with cardiac resynchronization therapy. European journal of heart failure, 13(10), 1126-1132. https://doi.org/10.1093/eurjhf/hfr094
    • van Almen, G. C., Verhesen, W., van Leeuwen, R. E. W., van de Vrie, M., Eurlings, C., Schellings, M. W. M., Swinnen, M., Cleutjens, J. P. M., van Zandvoort, M. A. M. J., Heymans, S., & Schroen, B. (2011). MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell, 10(5), 769-779. https://doi.org/10.1111/j.1474-9726.2011.00714.x
    • Weijs, B., Blaauw, Y., Rennenberg, R. J. M. W., Schurgers, L. J., Timmermans, C. C. M. M., Pison, L., Nieuwlaat, R., Hofstra, L., Kroon, A. A., Wildberger, J., & Crijns, H. J. G. M. (2011). Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. European Heart Journal, 32(20), 2555-2562. https://doi.org/10.1093/eurheartj/ehr226
    • Reilly, S. N., Jayaram, R., Nahar, K., Antoniades, C., Verheule, S., Channon, K. M., Alp, N. J., Schotten, U., & Casadei, B. (2011). Atrial Sources of Reactive Oxygen Species Vary With the Duration and Substrate of Atrial Fibrillation Implications for the Antiarrhythmic Effect of Statins. Circulation, 124(10), 1107-U91. https://doi.org/10.1161/CIRCULATIONAHA.111.029223
    • van Almen, G. C., Swinnen, M., Carai, P., Verhesen, W., Cleutjens, J. P. M., D'hooge, J., Verheyen, F. K., Pinto, Y. M., Schroen, B., Carmeliet, P., & Heymans, S. (2011). Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy. Journal of Molecular and Cellular Cardiology, 51(3), 318-328. https://doi.org/10.1016/j.yjmcc.2011.05.010
    • Linz, D., Schotten, U., Neuberger, H.-R., Boehm, M., & Wirth, K. (2011). Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm, 8(9), 1436-1443. https://doi.org/10.1016/j.hrthm.2011.03.053
    • Heemstra, H. E., Nieuwlaat, R., Meijboom, M., & Crijns, H. J. (2011). The burden of atrial fibrillation in the Netherlands. Netherlands Heart Journal, 19(9), 373-378. https://doi.org/10.1007/s12471-011-0175-4
    • Smit, M. D., Crijns, H. J. G. M., Tijssen, J. G. P., Hillege, H. L., Alings, M., Tuininga, Y. S., Groenveld, H. F., Van den Berg, M. P., van Veldhuisen, D. J., & Van Gelder, I. C. (2011). Effect of Lenient Versus Strict Rate Control on Cardiac Remodeling in Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 58(9), 942-949. https://doi.org/10.1016/j.jacc.2011.04.030
    • Torp-Pedersen, C., Crijns, H. J. G. M., Gaudin, C., Page, R. L., Connolly, S. J., & Hohnloser, S. H. (2011). Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study. EP Europace, 13(8), 1118-1126. https://doi.org/10.1093/europace/eur102
    • van den Wijngaard, A., Volders, P., van Tintelen, J. P., Jongbloed, J. D. H., van den Berg, M. P., Deprez, R. H. L., Mannens, M. M. A. M., Hofmann, N., van Slegtenhorst, M., Dooijes, D., Michels, M., Arens, Y., Jongbloed, R., & Smeets, B. J. M. (2011). Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy. Netherlands Heart Journal, 19(7-8), 344-351. https://doi.org/10.1007/s12471-011-0135-z
    • Camm, A. J., Breithardt, G., Crijns, H., Dorian, P., Kowey, P. R., Le Heuzey, J.-Y., Merioua, I., Pedrazzini, L., Prystowsky, E. N., Schwartz, P. J., Torp-Pedersen, C., & Weintraub, W. S. (2011). Real-Life Observations of Clinical Outcomes With Rhythm- and Rate-Control Therapies for Atrial Fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). Journal of the American College of Cardiology, 58(5), 493-501. https://doi.org/10.1016/j.jacc.2011.03.034
    • Foley, P. W. X., Chalil, S., Ratib, K., Smith, R., Prinzen, F., Auricchio, A., & Leyva, F. (2011). Fluoroscopic Left Ventricular Lead Position and the Long-Term Clinical Outcome of Cardiac Resynchronization Therapy. Pacing and Clinical Electrophysiology, 34(7), 785-797. https://doi.org/10.1111/j.1540-8159.2011.03114.x
    • La Meir, M., Gelsomino, S., Luca, F., Pison, L., Chambille, P., Parise, O., Crijns, H. J., & Maessen, J. G. (2011). Time-Related Prevalence of Postoperative Atrial Fibrillation After Stand-Alone Minimally Invasive Radiofrequency Ablation. Journal of Cardiac Surgery, 26(4), 453-459. https://doi.org/10.1111/j.1540-8191.2011.01272.x
    • Cox, M. G. P. J., van der Zwaag, P. A., van der Werf, C., van der Smagt, J. J., Noorman, M., Bhuiyan, Z. A., Wiesfeld, A. C. P., Volders, P. G. A., van Langen, I. M., Atsma, D. E., Dooijes, D., van den Wijngaard, A., Houweling, A. C., Jongbloed, J. D. H., Jordaens, L. J. L. M., Cramer, M. J., Doevendans, P. A., de Bakker, J. M. T., Wilde, A. A. M., ... Hauer, R. N. W. (2011). Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Pathogenic Desmosome Mutations in Index-Patients Predict Outcome of Family Screening: Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Genotype-Phenotype Follow-Up Study. Circulation, 123(23), 2690-2700. https://doi.org/10.1161/CIRCULATIONAHA.110.988287
    • Leyva, F., Foley, P. W. X., Chalil, S., Ratib, K., Smith, R. E. A., Prinzen, F., & Auricchio, A. (2011). Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 13, 9. https://doi.org/10.1186/1532-429X-13-29
    • Strik, M., Ploux, S., Vernooy, K., & Prinzen, F. W. (2011). Cardiac Resynchronization Therapy - Refocus on the Electrical Substrate. Circulation Journal, 75(6), 1297-1304. https://doi.org/10.1253/circj.CJ-11-0356
    • Postema, P. G., Christiaans, I., Hofman, N., Alders, M., Koopmann, T. T., Bezzina, C. R., Loh, P., Zeppenfeld, K., Volders, P. G. A., & Wilde, A. A. M. (2011). Founder mutations in the Netherlands: familial idiopathic ventricular fibrillation and DPP6. Netherlands Heart Journal, 19(6), 290-296. https://doi.org/10.1007/s12471-011-0102-8
    • Laverty, H. G., Benson, C., Cartwright, E. J., Cross, M. J., Garland, C., Hammond, T. R., Holloway, C., McMahon, N., Milligan, J., Park, B. K., Pirmohamed, M., Pollard, C., Radford, J., Roome, N., Sager, P., Singh, S., Suter, T., Suter, W., Trafford, A. W., ... Valentin, J. P. (2011). How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?British Journal of Pharmacology, 163(4), 675-693. https://doi.org/10.1111/j.1476-5381.2011.01255.x
    • van Geldorp, I. E., Vanagt, W. Y., Prinzen, F. W., & Delhaas, T. (2011). Chronic ventricular pacing in children: toward prevention of pacing-induced heart disease. Heart Failure Reviews, 16(3), 305-314. https://doi.org/10.1007/s10741-010-9207-1
    • Cornelussen, R. N., Splett, V., Klepfer, R. N., Stegemann, B., Kornet, L., & Prinzen, F. W. (2011). Electrical modalities beyond pacing for the treatment of heart failure. Heart Failure Reviews, 16(3), 315-325. https://doi.org/10.1007/s10741-010-9206-2
    • Dinh, T., Baur, L. H. B., Pisters, R., Kamp, O., Verheugt, F. W. A., Smeets, J. L. R. M., Cheriex, E. C., Tieleman, R. G., Prins, M. H., & Crijns, H. J. G. M. (2011). Feasibility of TEE-guided stroke risk assessment in atrial fibrillation-background, aims, design and baseline data of the TIARA pilot study. Netherlands Heart Journal, 19(5), 214-222. https://doi.org/10.1007/s12471-011-0095-3
    • Heijman, J., Volders, P. G. A., Westra, R. L., & Rudy, Y. (2011). Local control of β-adrenergic stimulation: Effects on ventricular myocyte electrophysiology and Ca2+-transient. Journal of Molecular and Cellular Cardiology, 50(5), 863-871. https://doi.org/10.1016/j.yjmcc.2011.02.007
    • Christiaans, I., Birnie, E., Bonsel, G. J., Mannens, M. M. A. M., Michels, M., Majoor-Krakauer, D., Dooijes, D., van Tintelen, J. P., Van den Berg, M. P., Volders, P. G. A., Arens, Y. H., van den Wijngaard, A., Atsma, D. E., Helderman-van den Enden, A. T. J. M., Houweling, A. C., de Boer, K., van der Smagt, J. J., Hauer, R. N. W., Marcelis, C. L. M., ... Wilde, A. A. M. (2011). Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy. European Heart Journal, 32(9), 1161-1170. https://doi.org/10.1093/eurheartj/ehr092